Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Preferred Shares (2017 - 2025)

Fortress Biotech has reported Preferred Shares over the past 9 years, most recently at $3000.0 for Q4 2025.

  • Quarterly results put Preferred Shares at $3000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $3000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $3000.0, changed 0.0%.
  • Preferred Shares for Q4 2025 was $3000.0 at Fortress Biotech, roughly flat from $3000.0 in the prior quarter.
  • Over the last five years, Preferred Shares for FBIO hit a ceiling of $3000.0 in Q1 2021 and a floor of $3000.0 in Q1 2021.
  • Median Preferred Shares over the past 5 years was $3000.0 (2021), compared with a mean of $3000.0.
  • Peak annual rise in Preferred Shares hit 50.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Fortress Biotech's Preferred Shares stood at $3000.0 in 2021, then changed by 0.0% to $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
  • The last three reported values for Preferred Shares were $3000.0 (Q4 2025), $3000.0 (Q3 2025), and $3000.0 (Q2 2025) per Business Quant data.